An A1C of 6.7% is NOT diagnostic for diabetes on its own—it requires confirmation with a repeat test.
A single A1C of 6.7% exceeds the diagnostic threshold of ≥6.5%, but according to current guidelines, you must confirm the diagnosis with either a repeat A1C or a second abnormal test (such as fasting plasma glucose ≥126 mg/dL) before labeling someone as diabetic 1, 2.
Diagnostic Criteria and Confirmation Requirements
The American Diabetes Association establishes that diabetes is diagnosed when:
- A1C ≥6.5% (performed in an NGSP-certified laboratory), OR
- Fasting plasma glucose ≥126 mg/dL, OR
- 2-hour plasma glucose ≥200 mg/dL during OGTT, OR
- Random plasma glucose ≥200 mg/dL with classic hyperglycemic symptoms 1, 2
The Critical Confirmation Step
Unless the patient presents with unequivocal hyperglycemia (classic symptoms plus random glucose >200 mg/dL or hyperglycemic crisis), any single abnormal test result must be confirmed 1, 2. This applies to your A1C of 6.7%.
The confirmation can occur in two ways:
Repeat the same test: If the initial A1C is 6.7% and a repeat A1C is 6.5% or higher, diabetes is confirmed 1, 2
Use a different test: If both A1C ≥6.5% AND fasting glucose ≥126 mg/dL are documented (either from the same sample or two different samples), diabetes is confirmed 1, 2
When Results Are Discordant
If you have an A1C of 6.7% but a normal fasting glucose (<126 mg/dL), repeat the test that is above the diagnostic threshold. The diagnosis is made based on whichever test confirms as abnormal on repeat testing. If two A1C measurements are both ≥6.5%, that person has diabetes even if fasting glucose remains normal 1, 2.
Important Clinical Caveats
When A1C Should NOT Be Used
Do not use A1C for diagnosis in conditions with altered red blood cell turnover 1:
- Sickle cell disease
- Pregnancy (second and third trimesters)
- Glucose-6-phosphate dehydrogenase deficiency
- Hemodialysis
- Recent blood loss or transfusion
- Erythropoietin therapy
- Iron-deficiency anemia
- HIV on certain antiretroviral drugs
In these situations, use only plasma glucose criteria (fasting or 2-hour post-load glucose) 1.
Laboratory Quality Matters
The A1C must be performed in a laboratory using an NGSP-certified method standardized to the DCCT assay. Point-of-care A1C devices, while convenient for monitoring known diabetes, are not sufficiently accurate for diagnostic purposes unless they meet strict CLIA certification and quality standards 1, 2.
The Sensitivity Issue
It's worth noting that A1C ≥6.5% identifies approximately one-third fewer cases of diabetes compared to fasting glucose ≥126 mg/dL when used for universal screening 3. Research confirms this: one study found A1C ≥6.5% had only 43.3% sensitivity compared to fasting glucose criteria and 28.1% sensitivity compared to 2-hour glucose criteria 4.
This means if clinical suspicion for diabetes is high but A1C is 6.4% or lower, consider obtaining fasting glucose or an oral glucose tolerance test 4, 5.
Practical Algorithm
For your patient with A1C 6.7%:
Confirm there are no conditions affecting A1C accuracy (hemoglobinopathies, anemia, recent blood loss)
Check for classic symptoms: If polyuria, polydipsia, unexplained weight loss, or hyperglycemic crisis are present with any random glucose >200 mg/dL, diabetes is confirmed without need for repeat testing 1, 2
If asymptomatic: Repeat the A1C test (preferred) or obtain a fasting plasma glucose
If results remain borderline (6.0-6.4% range): This represents very high risk for progression to diabetes—consider the patient as having prediabetes requiring intensive lifestyle intervention and close monitoring 6, 7
The bottom line: A single A1C of 6.7% is highly suggestive but not definitively diagnostic until confirmed by repeat testing 1, 2.